Tanagala, K. K. K., Morin-Baxter, J., Carvajal, R., Cheema, M., Dubey, S., Nakagawa, H., Yoon, A., Cheng, Y.-S. L., Taylor, A., Nickerson, J., Mintz, A., & Momen-Heravi, F. (2022). SP140 inhibits STAT1 signaling, induces IFN-γ in tumor-associated macrophages, and is a predictive biomarker of immunotherapy response. Journal for ImmunoTherapy of Cancer, 10(12), e005088. https://doi.org/10.1136/jitc-2022-005088
Publication Date
Columbia Affiliation
Vagelos College of Physicians and Surgeons; Department of Pathology and Cell Biology; Department of Medicine; Division of Digestive and Liver Diseases; Herbert Irving Comprehensive Cancer Center; Department of Radiology; College of Dental Medicine; Section of Oral, Diagnostic, and Rehabilitation Sciences